Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 47 of 47 entries
Sorted by: Best Match Show Resources per page
Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated With Cystic Airspaces: A Systematic Review and Meta-Analysis.

AJR. American journal of roentgenology

Mendoza DP, Heeger A, Mino-Kenudson M, Lanuti M, Shepard JO, Sequist LV, Digumarthy SR.
PMID: 32755209
AJR Am J Roentgenol. 2021 Feb;216(2):318-329. doi: 10.2214/AJR.20.23835. Epub 2020 Dec 23.

No abstract available.

Cite
Mendoza DP, Heeger A, Mino-Kenudson M, et al. Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated With Cystic Airspaces: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2020;216(2):318-329doi: 10.2214/AJR.20.23835.
Mendoza, D. P., Heeger, A., Mino-Kenudson, M., Lanuti, M., Shepard, J. O., Sequist, L. V., & Digumarthy, S. R. (2021). Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated With Cystic Airspaces: A Systematic Review and Meta-Analysis. AJR. American journal of roentgenology, 216(2), 318-329. https://doi.org/10.2214/AJR.20.23835
Mendoza, Dexter P, et al. "Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated With Cystic Airspaces: A Systematic Review and Meta-Analysis." AJR. American journal of roentgenology vol. 216,2 (2021): 318-329. doi: https://doi.org/10.2214/AJR.20.23835
Mendoza DP, Heeger A, Mino-Kenudson M, Lanuti M, Shepard JO, Sequist LV, Digumarthy SR. Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated With Cystic Airspaces: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2021 Feb;216(2):318-329. doi: 10.2214/AJR.20.23835. Epub 2020 Dec 23. PMID: 32755209.
Copy Download .nbib Format: NLM
A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.

Journal of thrombosis and thrombolysis

Li S, Gao P, Qiu J, He X, Mao Y.
PMID: 33599857
J Thromb Thrombolysis. 2021 Oct;52(3):898-903. doi: 10.1007/s11239-021-02396-5. Epub 2021 Feb 18.

The aim of this study was to evaluate the Khorana score and modified Khorana score as risk assessment tools for predicting the development of VTE in newly diagnosed advanced lung cancer. Information on the clinical data and laboratory indicators...

Cite
Li S, Gao P, Qiu J, et al. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer. J Thromb Thrombolysis. 2021;52(3):898-903doi: 10.1007/s11239-021-02396-5.
Li, S., Gao, P., Qiu, J., He, X., & Mao, Y. (2021). A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer. Journal of thrombosis and thrombolysis, 52(3), 898-903. https://doi.org/10.1007/s11239-021-02396-5
Li, Shuangping, et al. "A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer." Journal of thrombosis and thrombolysis vol. 52,3 (2021): 898-903. doi: https://doi.org/10.1007/s11239-021-02396-5
Li S, Gao P, Qiu J, He X, Mao Y. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer. J Thromb Thrombolysis. 2021 Oct;52(3):898-903. doi: 10.1007/s11239-021-02396-5. Epub 2021 Feb 18. PMID: 33599857.
Copy Download .nbib Format: NLM
[COPD and lung cancer: practical implications].

Archivos de bronconeumologia

Díez Herranz A.
PMID: 11412516
Arch Bronconeumol. 2001 May;37(5):240-7. doi: 10.1016/s0300-2896(01)75061-2.

No abstract available.

Cite
Díez Herranz A. Enfermedad pulmonar obstructiva crónica y cáncer de pulmón: implicaciones prácticas. [COPD and lung cancer: practical implications]. Arch Bronconeumol. 2001;37(5):240-7doi: 10.1016/s0300-2896(01)75061-2.
Díez Herranz, A. (2001). Enfermedad pulmonar obstructiva crónica y cáncer de pulmón: implicaciones prácticas. [COPD and lung cancer: practical implications]. Archivos de bronconeumologia, 37(5), 240-7. https://doi.org/10.1016/s0300-2896(01)75061-2
Díez Herranz, A. "Enfermedad pulmonar obstructiva crónica y cáncer de pulmón: implicaciones prácticas." [COPD and lung cancer: practical implications]. Archivos de bronconeumologia vol. 37,5 (2001): 240-7. doi: https://doi.org/10.1016/s0300-2896(01)75061-2
Díez Herranz A. Enfermedad pulmonar obstructiva crónica y cáncer de pulmón: implicaciones prácticas. [COPD and lung cancer: practical implications]. Arch Bronconeumol. 2001 May;37(5):240-7. doi: 10.1016/s0300-2896(01)75061-2. Spanish. PMID: 11412516.
Copy Download .nbib Format: NLM
Unusual metastatic behaviour of double primary tumours of prostate and lung.

Journal of the Irish Medical Association

TOWERS RP.
PMID: 13777771
J Ir Med Assoc. 1961 Mar;48:79-80.

No abstract available.

Cite
TOWERS RP. Unusual metastatic behaviour of double primary tumours of prostate and lung. J Ir Med Assoc. 1961;48:79-80
TOWERS, R. P. (1961). Unusual metastatic behaviour of double primary tumours of prostate and lung. Journal of the Irish Medical Association, 4879-80.
TOWERS, R P. "Unusual metastatic behaviour of double primary tumours of prostate and lung." Journal of the Irish Medical Association vol. 48 (1961): 79-80.
TOWERS RP. Unusual metastatic behaviour of double primary tumours of prostate and lung. J Ir Med Assoc. 1961 Mar;48:79-80. PMID: 13777771.
Copy Download .nbib Format: NLM
[Mortality in lung cancer and COPD].

Archivos de bronconeumologia

Soriano JB.
PMID: 20096983
Arch Bronconeumol. 2010 May;46(5):281-2; author reply 282. doi: 10.1016/j.arbres.2009.11.010. Epub 2010 Jan 22.

No abstract available.

Cite
Soriano JB. Mortalidad en cáncer de pulmón y en enfermedad pulmonar obstructiva crónica. [Mortality in lung cancer and COPD]. Arch Bronconeumol. 2010;46(5):281-2; author reply 282doi: 10.1016/j.arbres.2009.11.010.
Soriano, J. B. (2010). Mortalidad en cáncer de pulmón y en enfermedad pulmonar obstructiva crónica. [Mortality in lung cancer and COPD]. Archivos de bronconeumologia, 46(5), 281-2; author reply 282. https://doi.org/10.1016/j.arbres.2009.11.010
Soriano, Joan B. "Mortalidad en cáncer de pulmón y en enfermedad pulmonar obstructiva crónica." [Mortality in lung cancer and COPD]. Archivos de bronconeumologia vol. 46,5 (2010): 281-2; author reply 282. doi: https://doi.org/10.1016/j.arbres.2009.11.010
Soriano JB. Mortalidad en cáncer de pulmón y en enfermedad pulmonar obstructiva crónica. [Mortality in lung cancer and COPD]. Arch Bronconeumol. 2010 May;46(5):281-2; author reply 282. doi: 10.1016/j.arbres.2009.11.010. Epub 2010 Jan 22. Spanish. PMID: 20096983.
Copy Download .nbib Format: NLM
[Oncological emergencies].

Revue des maladies respiratoires

Meert AP.
PMID: 18971839
Rev Mal Respir. 2008 Oct;25(8):3S145-50.

No abstract available.

Cite
Meert AP. Les urgences oncologiques. [Oncological emergencies]. Rev Mal Respir. 2008;25(8):3S145-50
Meert, A. P. (2008). Les urgences oncologiques. [Oncological emergencies]. Revue des maladies respiratoires, 25(8), 3S145-50.
Meert, A-P. "Les urgences oncologiques." [Oncological emergencies]. Revue des maladies respiratoires vol. 25,8 (2008): 3S145-50.
Meert AP. Les urgences oncologiques. [Oncological emergencies]. Rev Mal Respir. 2008 Oct;25(8):3S145-50. French. PMID: 18971839.
Copy Download .nbib Format: NLM
Hypertrophic pulmonary osteoarthropathy.

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete

LAVICKA J, BLAHOS J.
PMID: 13570189
Z Gesamte Inn Med. 1957 Oct 15;12(20):944-6.

No abstract available.

Cite
LAVICKA J, BLAHOS J. Hypertrophische pulmonale Osteoarthropathie. Hypertrophic pulmonary osteoarthropathy. Z Gesamte Inn Med. 1957;12(20):944-6
LAVICKA, J., & BLAHOS, J. (1957). Hypertrophische pulmonale Osteoarthropathie. Hypertrophic pulmonary osteoarthropathy. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 12(20), 944-6.
LAVICKA, J, and BLAHOS, J. "Hypertrophische pulmonale Osteoarthropathie." Hypertrophic pulmonary osteoarthropathy. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete vol. 12,20 (1957): 944-6.
LAVICKA J, BLAHOS J. Hypertrophische pulmonale Osteoarthropathie. Hypertrophic pulmonary osteoarthropathy. Z Gesamte Inn Med. 1957 Oct 15;12(20):944-6. German. PMID: 13570189.
Copy Download .nbib Format: NLM
[Paraneoplastic neurological syndrome in 64-year-old patient in association with a small cell lung carcinoma].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Prouzová Z, Brychtová S.
PMID: 23301652
Klin Onkol. 2012;25(6):471-5.

BACKGROUND: Paraneoplastic neurological syndromes are rare conditions manifest as psychiatric/neurological symptoms. They are caused by autoimmunne cross-reaction leading to destruction of the central nervous system.CASE: We present the case of a 64-year-old patient hospitalized for 6 months at the...

Cite
Prouzová Z, Brychtová S. Paraneoplastický neurologický syndrom u 64letého pacienta s malobuněčným karcinomem plic - kazuistika. [Paraneoplastic neurological syndrome in 64-year-old patient in association with a small cell lung carcinoma]. Klin Onkol. 2012;25(6):471-5
Prouzová, Z., & Brychtová, S. (2012). Paraneoplastický neurologický syndrom u 64letého pacienta s malobuněčným karcinomem plic - kazuistika. [Paraneoplastic neurological syndrome in 64-year-old patient in association with a small cell lung carcinoma]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 25(6), 471-5.
Prouzová, Z, and Brychtová, S. "Paraneoplastický neurologický syndrom u 64letého pacienta s malobuněčným karcinomem plic - kazuistika." [Paraneoplastic neurological syndrome in 64-year-old patient in association with a small cell lung carcinoma]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti vol. 25,6 (2012): 471-5.
Prouzová Z, Brychtová S. Paraneoplastický neurologický syndrom u 64letého pacienta s malobuněčným karcinomem plic - kazuistika. [Paraneoplastic neurological syndrome in 64-year-old patient in association with a small cell lung carcinoma]. Klin Onkol. 2012;25(6):471-5. Czech. PMID: 23301652.
Copy Download .nbib Format: NLM
[Three Cases of Small-Cell Lung Cancer with Anti-Hu Antibody-Positive Paraneoplastic Neurological Syndrome].

Gan to kagaku ryoho. Cancer & chemotherapy

Horio J, Matsuzaki T, Iwami E, Terashima T.
PMID: 32541176
Gan To Kagaku Ryoho. 2020 Jun;47(6):967-971.

This case series discusses 3 male patients in their 60s who presented with a chief complaint of sensory disorder in the upper or lower limbs. The patients were diagnosed with small-cell lung cancer(SCLC)with anti-Hu antibody-positive paraneoplastic neurological syndrome(PNS). Chest...

Cite
Horio J, Matsuzaki T, Iwami E, et al. [Three Cases of Small-Cell Lung Cancer with Anti-Hu Antibody-Positive Paraneoplastic Neurological Syndrome]. Gan To Kagaku Ryoho. 2020;47(6):967-971
Horio, J., Matsuzaki, T., Iwami, E., & Terashima, T. (2020). [Three Cases of Small-Cell Lung Cancer with Anti-Hu Antibody-Positive Paraneoplastic Neurological Syndrome]. Gan to kagaku ryoho. Cancer & chemotherapy, 47(6), 967-971.
Horio, Joji, et al. "[Three Cases of Small-Cell Lung Cancer with Anti-Hu Antibody-Positive Paraneoplastic Neurological Syndrome]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 47,6 (2020): 967-971.
Horio J, Matsuzaki T, Iwami E, Terashima T. [Three Cases of Small-Cell Lung Cancer with Anti-Hu Antibody-Positive Paraneoplastic Neurological Syndrome]. Gan To Kagaku Ryoho. 2020 Jun;47(6):967-971. Japanese. PMID: 32541176.
Copy Download .nbib Format: NLM
Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Wong ML, Paul SM, Cooper BA, Dunn LB, Hammer MJ, Conley YP, Wright F, Levine JD, Walter LC, Cartwright F, Miaskowski C.
PMID: 28160076
Support Care Cancer. 2017 Jun;25(6):1931-1939. doi: 10.1007/s00520-017-3593-z. Epub 2017 Feb 03.

PURPOSE: Few studies have examined interindividual variability in the symptom experience of lung cancer patients. We aimed to identify the most prevalent, severe, and distressing symptoms, and risk factors associated with increased symptom burden.METHODS: Lung cancer patients (n =...

Cite
Wong ML, Paul SM, Cooper BA, et al. Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy. Support Care Cancer. 2017;25(6):1931-1939doi: 10.1007/s00520-017-3593-z.
Wong, M. L., Paul, S. M., Cooper, B. A., Dunn, L. B., Hammer, M. J., Conley, Y. P., Wright, F., Levine, J. D., Walter, L. C., Cartwright, F., & Miaskowski, C. (2017). Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 25(6), 1931-1939. https://doi.org/10.1007/s00520-017-3593-z
Wong, Melisa L, et al. "Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 25,6 (2017): 1931-1939. doi: https://doi.org/10.1007/s00520-017-3593-z
Wong ML, Paul SM, Cooper BA, Dunn LB, Hammer MJ, Conley YP, Wright F, Levine JD, Walter LC, Cartwright F, Miaskowski C. Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy. Support Care Cancer. 2017 Jun;25(6):1931-1939. doi: 10.1007/s00520-017-3593-z. Epub 2017 Feb 03. PMID: 28160076; PMCID: PMC5433346.
Copy Download .nbib Format: NLM
Home Coping Strategies for Fatigue Used by Patients With Lung Cancer Receiving Chemotherapy in Rural China: A Qualitative Study.

The journal of nursing research : JNR

Dong X, Peng J, Li X, Zhao Q, Zhang X.
PMID: 34483303
J Nurs Res. 2021 Sep 03;29(6):e178. doi: 10.1097/jnr.0000000000000453.

BACKGROUND: Cancer-related fatigue, a distressing symptom, is frequently reported by patients with lung cancer as increasing in severity with the number of rounds of chemotherapy. Yet, patients and healthcare providers are challenged to control this fatigue. Thus, healthcare providers...

Cite
Dong X, Peng J, Li X, et al. Home Coping Strategies for Fatigue Used by Patients With Lung Cancer Receiving Chemotherapy in Rural China: A Qualitative Study. J Nurs Res. 2021;29(6):e178doi: 10.1097/jnr.0000000000000453.
Dong, X., Peng, J., Li, X., Zhao, Q., & Zhang, X. (2021). Home Coping Strategies for Fatigue Used by Patients With Lung Cancer Receiving Chemotherapy in Rural China: A Qualitative Study. The journal of nursing research : JNR, 29(6), e178. https://doi.org/10.1097/jnr.0000000000000453
Dong, Xiaomeng, et al. "Home Coping Strategies for Fatigue Used by Patients With Lung Cancer Receiving Chemotherapy in Rural China: A Qualitative Study." The journal of nursing research : JNR vol. 29,6 (2021): e178. doi: https://doi.org/10.1097/jnr.0000000000000453
Dong X, Peng J, Li X, Zhao Q, Zhang X. Home Coping Strategies for Fatigue Used by Patients With Lung Cancer Receiving Chemotherapy in Rural China: A Qualitative Study. J Nurs Res. 2021 Sep 03;29(6):e178. doi: 10.1097/jnr.0000000000000453. PMID: 34483303.
Copy Download .nbib Format: NLM
Showing 37 to 47 of 47 entries